Sandostatin Lar 20 mg powder and solvent for suspension for injection

国家: 保加利亚

语言: 保加利亚文

来源: Изпълнителна агенция по лекарствата

现在购买

资料单张 资料单张 (PIL)
15-01-2024
产品特点 产品特点 (SPC)
30-01-2023

有效成分:

Октреотид

可用日期:

Novartis Pharma GmbH

ATC代码:

H01CB2

INN(国际名称):

Octreotide

剂量:

20 mg powder and solvent for suspension for injection

產品總結:

Sandostatin LAR, 20 mg powder and solvent for suspension for injection

授权日期:

2015-03-11